1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Amgen Inc.
- Eli Lilly and Company
- Novartis AG
- Pfizer Inc.
- Radius Health, Inc.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The availability of reimbursement programs for patients with osteoporosis will drive the market growth during the forecast period. Osteoporosis is the most prevalent among the geriatric population. Therefore, major markets such as the US, Germany, Japan, the UK, France, Canada, Spain, and other developed European countries are providing reimbursement schemes. The analysts have predicted that the osteoporosis drugs market will register a CAGR of almost 5% by 2023.
Market Overview
Increasing prevalence of osteoporosis
Osteoporosis prevalence has increased worldwide due to which it is considered a serious public health concern. Osteoporosis is more common in older women than in older men. The improved standards of healthcare facilities and sophisticated treatment options have increased the life expectancy rates, augmenting the aging population
Side effects of osteoporosis drugs
Side effects of bisphosphonates such as alendronate, ibandronate, risedronate, and zoledronic acid may include muscle pain, joint pain, nausea, difficulty swallowing, heartburn, irritation of the esophagus, and gastric ulcers. Also, these drugs can cause osteonecrosis of the jaw. The risk of osteonecrosis of the jaw in an individual increase with treatment periods longer than 5 years.
For the detailed list of factors that will drive and challenge the growth of the osteoporosis drugs market during the 2019-2023, view this report.
Competitive Landscape
The market appears to be moderately fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Market Overview
Increasing prevalence of osteoporosis
Osteoporosis prevalence has increased worldwide due to which it is considered a serious public health concern. Osteoporosis is more common in older women than in older men. The improved standards of healthcare facilities and sophisticated treatment options have increased the life expectancy rates, augmenting the aging population
Side effects of osteoporosis drugs
Side effects of bisphosphonates such as alendronate, ibandronate, risedronate, and zoledronic acid may include muscle pain, joint pain, nausea, difficulty swallowing, heartburn, irritation of the esophagus, and gastric ulcers. Also, these drugs can cause osteonecrosis of the jaw. The risk of osteonecrosis of the jaw in an individual increase with treatment periods longer than 5 years.
For the detailed list of factors that will drive and challenge the growth of the osteoporosis drugs market during the 2019-2023, view this report.
Competitive Landscape
The market appears to be moderately fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Amgen Inc.
- Eli Lilly and Company
- Novartis AG
- Pfizer Inc.
- Radius Health, Inc.
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORKPART 11: MARKET TRENDS
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Amgen Inc.
- Eli Lilly and Company
- Novartis AG
- Pfizer Inc.
- Radius Health, Inc.
Global Osteoporosis Drugs Market 2019-2023
The analyst recognizes the following companies as the key players in the global osteoporosis drugs market: Amgen Inc., Eli Lilly and Company, Novartis AG, Pfizer Inc., Radius Health, Inc..
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increase in strategic alliances.”
According to the report, one of the major drivers for this market is the reimbursement programs and coverage of drug by health insurance.
Further, the report states that one of the major factors hindering the growth of this market is the poor diagnosis and drug treatment rates.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The analyst recognizes the following companies as the key players in the global osteoporosis drugs market: Amgen Inc., Eli Lilly and Company, Novartis AG, Pfizer Inc., Radius Health, Inc..
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increase in strategic alliances.”
According to the report, one of the major drivers for this market is the reimbursement programs and coverage of drug by health insurance.
Further, the report states that one of the major factors hindering the growth of this market is the poor diagnosis and drug treatment rates.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Amgen Inc.
- Eli Lilly and Company
- Novartis AG
- Pfizer Inc.
- Radius Health, Inc.
Note: Product cover images may vary from those shown
